Drive Wealth Management LLC Sells 1,952 Shares of UnitedHealth Group Incorporated $UNH

Drive Wealth Management LLC lessened its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 48.4% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 2,082 shares of the healthcare conglomerate’s stock after selling 1,952 shares during the quarter. Drive Wealth Management LLC’s holdings in UnitedHealth Group were worth $650,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Brighton Jones LLC lifted its position in UnitedHealth Group by 176.2% during the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock worth $22,384,000 after purchasing an additional 28,231 shares during the period. Revolve Wealth Partners LLC lifted its position in UnitedHealth Group by 137.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock worth $2,033,000 after purchasing an additional 2,324 shares during the period. GAMMA Investing LLC lifted its position in UnitedHealth Group by 7.4% during the first quarter. GAMMA Investing LLC now owns 15,838 shares of the healthcare conglomerate’s stock worth $8,295,000 after purchasing an additional 1,089 shares during the period. Intact Investment Management Inc. lifted its position in UnitedHealth Group by 120.0% during the first quarter. Intact Investment Management Inc. now owns 2,200 shares of the healthcare conglomerate’s stock worth $1,152,000 after purchasing an additional 1,200 shares during the period. Finally, MPS Loria Financial Planners LLC lifted its position in UnitedHealth Group by 0.4% during the first quarter. MPS Loria Financial Planners LLC now owns 7,256 shares of the healthcare conglomerate’s stock worth $3,800,000 after purchasing an additional 27 shares during the period. Institutional investors own 87.86% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on the stock. UBS Group reaffirmed a “buy” rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Baird R W cut shares of UnitedHealth Group from a “hold” rating to a “strong sell” rating in a report on Thursday, July 31st. Wells Fargo & Company increased their target price on shares of UnitedHealth Group from $267.00 to $400.00 and gave the stock an “overweight” rating in a report on Tuesday, October 7th. Oppenheimer dropped their target price on shares of UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating for the company in a report on Wednesday, July 30th. Finally, KeyCorp increased their target price on shares of UnitedHealth Group from $350.00 to $400.00 and gave the stock an “overweight” rating in a report on Wednesday, October 8th. Eighteen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and four have assigned a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $385.13.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $356.53 on Monday. The company has a market capitalization of $322.90 billion, a PE ratio of 15.45, a P/E/G ratio of 2.31 and a beta of 0.47. The company has a 50 day simple moving average of $329.38 and a two-hundred day simple moving average of $342.24. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The firm had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business’s revenue for the quarter was up 12.9% compared to the same quarter last year. During the same period in the prior year, the company posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were issued a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s dividend payout ratio is presently 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.